Source: Atherosclerosis. Unidades: FCF, ICB
Subjects: ARTERIOSCLEROSE, MACRÓFAGOS, ENDOTÉLIO, LEUCÓCITOS
ABNT
BITTENCOURT JUNIOR, Paulo Ivo Homem de et al. LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions. Atherosclerosis, v. 193, n. 2, p. 245-258, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2006.08.049. Acesso em: 05 nov. 2024.APA
Bittencourt Junior, P. I. H. de, Lagranha, D. J., Maslinkiewicz, A., Senna, S. M., Tavares, A. M. V., Baldissera, L. P., et al. (2007). LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions. Atherosclerosis, 193( 2), 245-258. doi:10.1016/j.atherosclerosis.2006.08.049NLM
Bittencourt Junior PIH de, Lagranha DJ, Maslinkiewicz A, Senna SM, Tavares AMV, Baldissera LP, Janner D da R, Peralta J dos S, Bock PM, Gutierrez LLP, Scola G, Heck TG, Krause M da S, Cruz LA, Abdalla DSP, Lagranha CJ, Lima T, Curi R. LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions [Internet]. Atherosclerosis. 2007 ; 193( 2): 245-258.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2006.08.049Vancouver
Bittencourt Junior PIH de, Lagranha DJ, Maslinkiewicz A, Senna SM, Tavares AMV, Baldissera LP, Janner D da R, Peralta J dos S, Bock PM, Gutierrez LLP, Scola G, Heck TG, Krause M da S, Cruz LA, Abdalla DSP, Lagranha CJ, Lima T, Curi R. LipoCardium: Endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions [Internet]. Atherosclerosis. 2007 ; 193( 2): 245-258.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2006.08.049